0A8S vs ABT: Side-by-Side Comparison
Compare Sintx Technologies, Inc. (0A8S) and Abbott Laboratories (ABT) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | 0A8S | ABT |
|---|---|---|
| Company | Sintx Technologies, Inc. | Abbott Laboratories |
| Country / Exchange | United States · LSE | United States · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Market cap | — | USD 166.17B |
| P/E ratio | — | 26.6 |
| Dividend yield | — | 2.56% |
| Valuation model | — | 9.4% undervalued |
| Revenue (latest FY) | — | USD 44.33B |
| Revenue growth YoY | — | +5.7% |
| Net income | — | USD 6.52B |
| Gross margin | — | 56.4% |
| Diluted EPS | — | 3.72 |